ZA9725B - 4,5-Dihydronaphth[1,2-c]isoxazoles and derivatives thereof - Google Patents
4,5-Dihydronaphth[1,2-c]isoxazoles and derivatives thereofInfo
- Publication number
- ZA9725B ZA9725B ZA9725A ZA9725A ZA9725B ZA 9725 B ZA9725 B ZA 9725B ZA 9725 A ZA9725 A ZA 9725A ZA 9725 A ZA9725 A ZA 9725A ZA 9725 B ZA9725 B ZA 9725B
- Authority
- ZA
- South Africa
- Prior art keywords
- dihydronaphth
- isoxazoles
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58331996A | 1996-01-05 | 1996-01-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA9725B true ZA9725B (en) | 1997-07-07 |
Family
ID=24332609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9725A ZA9725B (en) | 1996-01-05 | 1997-01-02 | 4,5-Dihydronaphth[1,2-c]isoxazoles and derivatives thereof |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0874833A1 (fr) |
JP (1) | JP3161737B2 (fr) |
KR (1) | KR100308748B1 (fr) |
CN (1) | CN1214046A (fr) |
AR (1) | AR005347A1 (fr) |
AU (1) | AU710059B2 (fr) |
BR (1) | BR9612578A (fr) |
CA (1) | CA2241845C (fr) |
HU (1) | HUP9903706A3 (fr) |
IL (1) | IL125197A0 (fr) |
NO (1) | NO983100L (fr) |
NZ (1) | NZ325587A (fr) |
WO (1) | WO1997025317A1 (fr) |
ZA (1) | ZA9725B (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050131051A1 (en) * | 2000-08-21 | 2005-06-16 | Shaomeng Wang | 2-3-disubstituted quinuclidiness as modulators of monoamine transporters and theraperutic and diagnostic methods based thereon |
MXPA04008626A (es) * | 2002-04-02 | 2004-12-06 | Janssen Pharmaceutica Nv | Derivados de amino isoxazolina sustituidos y su uso como antidepresivos. |
AR040967A1 (es) | 2002-08-12 | 2005-04-27 | Janssen Pharmaceutica Nv | Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos |
JP4478571B2 (ja) | 2002-08-15 | 2010-06-09 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 縮合複素環式イソオキサゾリン誘導体及び抗うつ薬としてのそれらの使用 |
MY134287A (en) | 2002-08-21 | 2007-11-30 | Janssen Pharmaceutica Nv | C6- and c9-substituted isoxazoline derivatives and their use as anti-depressants |
US8025859B2 (en) | 2007-05-18 | 2011-09-27 | Cesl Limited | Process for gold and silver recovery from a sulphide concentrate |
ES2759949T3 (es) | 2009-10-29 | 2020-05-12 | Bristol Myers Squibb Co | Compuestos heterocíclicos tricíclicos |
EP3507278B1 (fr) | 2016-09-02 | 2021-01-27 | Bristol-Myers Squibb Company | Composés hétérocycliques tricycliques substitués |
US11046646B2 (en) | 2017-08-09 | 2021-06-29 | Bristol-Myers Squibb Company | Alkylphenyl compounds |
US11059784B2 (en) | 2017-08-09 | 2021-07-13 | Bristol-Myers Squibb Company | Oxime ether compounds |
KR102002633B1 (ko) | 2018-07-19 | 2019-07-22 | 김태효 | 완충이격부가 구비된 논슬립 발의류 |
KR102429797B1 (ko) | 2019-12-31 | 2022-08-05 | 주식회사 제이패션 | 기능성 무재봉 덧신 및 이를 제조하는 제조방법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2119977A1 (en) * | 1971-04-23 | 1971-12-16 | Teikoku Hormone Manufacturing Co , Ltd, Tokio | Antiphlogistic and antisecretory napththisoxazoles - from 1-hydroxyim - 2-carbonyl derivs by intramolecular condensation |
DE69021645T2 (de) * | 1989-05-19 | 1996-02-22 | Hoechst-Roussel Pharmaceuticals Inc., Somerville, N.J. | N-(aryloxyalkyl)heteroarylpiperidine und -heteroarylpiperazine, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente. |
WO1994010162A1 (fr) * | 1992-10-23 | 1994-05-11 | Merck Sharp & Dohme Limited | Ligands pour les sous-types de recepteurs de dopamine |
-
1996
- 1996-12-12 EP EP96944274A patent/EP0874833A1/fr not_active Withdrawn
- 1996-12-12 CA CA002241845A patent/CA2241845C/fr not_active Expired - Fee Related
- 1996-12-12 CN CN96180175A patent/CN1214046A/zh active Pending
- 1996-12-12 IL IL12519796A patent/IL125197A0/xx unknown
- 1996-12-12 HU HU9903706A patent/HUP9903706A3/hu unknown
- 1996-12-12 AU AU14126/97A patent/AU710059B2/en not_active Ceased
- 1996-12-12 JP JP52519797A patent/JP3161737B2/ja not_active Expired - Fee Related
- 1996-12-12 KR KR1019980705166A patent/KR100308748B1/ko not_active IP Right Cessation
- 1996-12-12 NZ NZ325587A patent/NZ325587A/xx unknown
- 1996-12-12 WO PCT/US1996/019569 patent/WO1997025317A1/fr not_active Application Discontinuation
- 1996-12-12 BR BR9612578A patent/BR9612578A/pt not_active Application Discontinuation
-
1997
- 1997-01-02 ZA ZA9725A patent/ZA9725B/xx unknown
- 1997-01-03 AR ARP970100015A patent/AR005347A1/es unknown
-
1998
- 1998-07-03 NO NO983100A patent/NO983100L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO983100D0 (no) | 1998-07-03 |
JP3161737B2 (ja) | 2001-04-25 |
BR9612578A (pt) | 1999-07-27 |
CA2241845A1 (fr) | 1997-07-17 |
AU1412697A (en) | 1997-08-01 |
HUP9903706A2 (hu) | 2000-08-28 |
EP0874833A1 (fr) | 1998-11-04 |
AU710059B2 (en) | 1999-09-09 |
NO983100L (no) | 1998-09-04 |
NZ325587A (en) | 1999-02-25 |
HUP9903706A3 (en) | 2000-09-28 |
IL125197A0 (en) | 1999-03-12 |
KR100308748B1 (ko) | 2001-12-12 |
WO1997025317A1 (fr) | 1997-07-17 |
CA2241845C (fr) | 2002-10-01 |
CN1214046A (zh) | 1999-04-14 |
KR19990077033A (ko) | 1999-10-25 |
JPH11510816A (ja) | 1999-09-21 |
AR005347A1 (es) | 1999-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2319250B (en) | Derivatives of 6,8-Difluoro-7-Hydroxycoumarin | |
NZ329176A (en) | 2,5-dioxo-imidazolidine derivatives and medicaments | |
IL120125A0 (en) | Substituted oxazolidinones their preparation and their use | |
IL121298A (en) | N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their uses | |
IL121299A0 (en) | 4-hydroxy-piperidine derivatives and their uses | |
IL111223A (en) | 3-phenylmethanoyl benzo [b] thiene derivatives and uses thereof | |
IL126968A0 (en) | Alkylaminobenzothiazole and benzoxazole derivatives | |
HUP9904032A3 (en) | 1,2,4-benzothiadiazine derivatives,their preparation and use | |
IL143095A0 (en) | 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives | |
ZA978876B (en) | Oxazolone derivatives and their use | |
ZA9725B (en) | 4,5-Dihydronaphth[1,2-c]isoxazoles and derivatives thereof | |
IL131645A (en) | Pyrimido ¬1,2-a¾indole derivatives and their preparation | |
HUP9900400A3 (en) | Isoxazole derivatives | |
HUP9902901A3 (en) | Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and 2-aminocyclohepta[b]benzofurans | |
AU2405397A (en) | Thienopyridine derivatives and their use | |
HK1023124A1 (en) | Oxime derivatives and their use as fungicides | |
GB2324090B (en) | 5,6-O-alkylidene glucono-1(4)-lactones and derivatives thereof,their preparation and use | |
HU9700609D0 (en) | 1,25-dihydroxy-12,22,23-trisdehydro-cholecalciferol derivatives | |
IL120285A (en) | Process for the preparation of 1,5-benzothiazepine derivatives, process for the preparation of the intermediate thereof and an intermediate thereof | |
ZA953749B (en) | 5,6-dihydro-4H-thieno[3,4-c] pyrroie derivatives their preparation and their therapeutic application | |
IL113150A0 (en) | 1,2,4-triazolo [4,3-a]pyrazin-4-one derivatives and preparation thereof | |
AU2153197A (en) | Cripowellins and synthetic derivatives thereof | |
IL129029A0 (en) | 8(9)-Dehydroestradiol derivatives | |
IL117864A0 (en) | Benzamidoxime derivatives their preparation and use | |
ZA973492B (en) | Thienopyridine derivatives and their use. |